Patrimony

The Louis Bachelier Group's patrimony has been defined as all the publications produced by academic researchers thanks to Group funding (ILB, FdR, IEF, Labex) or via the use of EquipEx data (BEDOFIH, EUROFIDAI).


Reset

Parallel convergences: a political economy of drug market access regulation in France and England.

Accès au marché, Bureaucratic politics, Capture, Health technology assessment, Industrie pharmaceutique, Market access, New public management, Nouveau management public, Pharmaceutical industry, Political economy, Politique bureaucratique, Regulation, Regulatory capture, Régulation, State, Économie politique, État, Évaluation des technologies de santé

Prospective mortality analyses: actuarial and biomedical approaches.

Biologie du vieillissement, Biology of aging, Biomedical developments, Clinical trials, Développements biomédicaux, Essais cliniques, Industrie pharmaceutique, Lee Carter, Longevity, Longévité, Megafund, Mortality rates, Méga fonds, Pharmaceutical industry, Taux de mortalité

Governing (through) Prices: The State and Pharmaceutical Pricing in France.

Behaviours, France, Market, Pharmaceutical Industry, Pharmaceuticals, Prices, Regulation, State, Values

Parallel convergences: a political economy of drug market access regulation in France and England.

Accès au marché, Bureaucratic politics, Capture, Health technology assessment, Industrie pharmaceutique, Market access, New public management, Nouveau management public, Pharmaceutical industry, Political economy, Politique bureaucratique, Regulatory capture, Régulation, State, Économie politique, État, Évaluation des technologies de santé

Integrating quantitative and qualitative findings in political economy: an illustration of four approaches.

Economic policy, Economic voting, Financial industry, Industrie financière, Industrie pharmaceutique, Pharmaceutical industry, Syndicalisation, Unionisation, Vote économique, Économie politique